Page last updated: 2024-08-23

pirfenidone and Aging

pirfenidone has been researched along with Aging in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glassberg, MK1
Hewitt, RJ; Maher, TM1
Abe, M; Hirasawa, Y; Sakayori, M; Suzuki, K; Tatsumi, K; Terada, J; Tsushima, K; Yoshioka, K1
Locy, ML; Luckhardt, TR; Rangarajan, S; Thannickal, VJ1
Corte, TJ; Jo, HE; Moodley, Y; Randhawa, S1

Reviews

3 review(s) available for pirfenidone and Aging

ArticleYear
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
    The American journal of managed care, 2019, Volume: 25, Issue:11 Suppl

    Topics: Age Distribution; Aging; Antineoplastic Agents; Chronic Disease; Comorbidity; Disease Progression; Health Expenditures; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Patient Education as Topic; Practice Guidelines as Topic; Pyridones; Sex Distribution

2019
Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options.
    Drugs & aging, 2019, Volume: 36, Issue:6

    Topics: Aging; Drug Development; Extracellular Matrix; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Pyridones; Randomized Controlled Trials as Topic

2019
Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?
    Drugs, 2016, Volume: 76, Issue:3

    Topics: Aging; Clinical Trials, Phase II as Topic; Drug Approval; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Molecular Targeted Therapy; Pyridones

2016

Other Studies

2 other study(ies) available for pirfenidone and Aging

ArticleYear
Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Adult; Aged; Aged, 80 and over; Aging; Anti-Inflammatory Agents, Non-Steroidal; Drug Tolerance; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones; Retrospective Studies; Treatment Outcome

2019
Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.
    Drugs & aging, 2016, Volume: 33, Issue:5

    Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Agents; Biopsy; Comorbidity; Disease Management; Disease Progression; Female; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Indoles; Male; Pyridones; Tomography, X-Ray Computed

2016